Latest Institutional Transactions on Vanda Pharmaceuticals Inc. (VNDA)
This table provides information on the latest institutional transactions involving Vanda Pharmaceuticals Inc. (VNDA) stock. The table includes the name of the institution, the type of operation (buy or sell), whether options were involved, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the transaction has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2018
Q1 2018
|
Oberweis Asset Management Inc
Lisle, IL |
SELL
|
- |
-10.7KClosed |
$150K - $216K
|
0
$0
|
|
|
May 15, 2018
Q1 2018
|
Highbridge Capital Management LLC
New York, NY |
SELL
|
CALL |
-18.1KClosed |
$254K - $366K
|
0
$0
|
|
|
May 15, 2018
Q1 2018
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-968KClosed |
$13.6M - $19.6M
|
0
$0
|
|
|
May 15, 2018
Q1 2018
|
Barclays PLC
London, X0 |
BUY
|
PUT |
600New |
$8.43K - $12.1K
|
600
$2.61K
|
|
|
May 14, 2018
Q1 2018
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
- |
137KNew |
$1.93M - $2.77M
|
137K
$597K
|
|
|
May 11, 2018
Q1 2018
|
Landscape Capital Management, L.L.C.
|
SELL
|
- |
-44.2KClosed |
$621K - $893K
|
0
$0
|
|
|
May 04, 2018
Q1 2018
|
D'Orazio & Associates, Inc.
Falls Church, VA |
SELL
|
- |
-1.5KClosed |
$21.1K - $30.3K
|
0
$0
|
|
| Q4 2017 | |||||||
|
Feb 14, 2018
Q4 2017
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-244KClosed |
$3.14M - $4.42M
|
0
$0
|
|
|
Feb 14, 2018
Q4 2017
|
Axiom Investors LLC
Greenwich, CT |
SELL
|
- |
-137KClosed |
$1.76M - $2.48M
|
0
$0
|
|
|
Feb 14, 2018
Q4 2017
|
Kingdon Capital Management, L.L.C.
New York, NY |
SELL
|
CALL |
-56.2KClosed |
$722K - $1.02M
|
0
$0
|
|
|
Feb 14, 2018
Q4 2017
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-36.2KClosed |
$466K - $656K
|
0
$0
|
|
|
Feb 13, 2018
Q4 2017
|
Gagnon Securities LLC
|
SELL
|
- |
-18.1KClosed |
$233K - $328K
|
0
$0
|
|
|
Feb 01, 2018
Q4 2017
|
Nationwide Fund Advisors
|
SELL
|
- |
-41.1KClosed |
$528K - $744K
|
0
$0
|
|
| Q3 2017 | |||||||
|
Mar 02, 2018
Q3 2017
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-62.9KClosed |
$969K - $1.19M
|
0
$0
|
|
|
Oct 30, 2017
Q3 2017
|
Thompson Davis & Co., Inc.
|
SELL
|
- |
-350Closed |
$5.39K - $6.6K
|
0
$0
|
|